149 related articles for article (PubMed ID: 17030871)
1. Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice.
Jayasekera JP; Vinuesa CG; Karupiah G; King NJC
J Gen Virol; 2006 Nov; 87(Pt 11):3361-3371. PubMed ID: 17030871
[TBL] [Abstract][Full Text] [Related]
2. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice.
Karupiah G; Chen JH; Mahalingam S; Nathan CF; MacMicking JD
J Exp Med; 1998 Oct; 188(8):1541-6. PubMed ID: 9782132
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
[TBL] [Abstract][Full Text] [Related]
4. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
Lund FE; Partida-Sánchez S; Lee BO; Kusser KL; Hartson L; Hogan RJ; Woodland DL; Randall TD
J Immunol; 2002 Nov; 169(9):5236-43. PubMed ID: 12391242
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner.
Weiss ID; Wald O; Wald H; Beider K; Abraham M; Galun E; Nagler A; Peled A
J Interferon Cytokine Res; 2010 Jun; 30(6):439-49. PubMed ID: 20235626
[TBL] [Abstract][Full Text] [Related]
7. Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene.
Liu B; Mori I; Hossain MJ; Dong L; Chen Z; Kimura Y
Microb Pathog; 2003 Apr; 34(4):161-7. PubMed ID: 12668139
[TBL] [Abstract][Full Text] [Related]
8. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.
Van Der Sluijs KF; Van Elden LJ; Arens R; Nijhuis M; Schuurman R; Florquin S; Kwakkel J; Akira S; Jansen HM; Lutter R; Van Der Polls T
Immunology; 2005 Jan; 114(1):112-20. PubMed ID: 15606801
[TBL] [Abstract][Full Text] [Related]
9. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
Latha K; Jamison KF; Watford WT
Front Immunol; 2021; 12():738490. PubMed ID: 34691044
[TBL] [Abstract][Full Text] [Related]
10. Control of influenza infection is impaired by diminished interferon-γ secretion by CD4 T cells in the lungs of toddler mice.
Verhoeven D; Perry S; Pryharski K
J Leukoc Biol; 2016 Jul; 100(1):203-12. PubMed ID: 26823488
[TBL] [Abstract][Full Text] [Related]
11. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
[TBL] [Abstract][Full Text] [Related]
13. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.
Graham MB; Dalton DK; Giltinan D; Braciale VL; Stewart TA; Braciale TJ
J Exp Med; 1993 Nov; 178(5):1725-32. PubMed ID: 8228818
[TBL] [Abstract][Full Text] [Related]
14. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
[TBL] [Abstract][Full Text] [Related]
15. IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice.
van der Sluijs KF; van Elden LJ; Xiao Y; Arens R; Nijhuis M; Schuurman R; Florquin S; Jansen HM; Lutter R; van der Poll T
Antiviral Res; 2006 Jun; 70(2):75-84. PubMed ID: 16490265
[TBL] [Abstract][Full Text] [Related]
16. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
17. [Changes in natural killer activity in the influenza virus infection of mice and in treating lymphocytes with the influenza virus and its proteins in vitro].
Trushinskaia GN; Gubareva LV; Parasiuk NA; Ivanova VT; Zhadanov VM
Vopr Virusol; 1988; 33(1):11-7. PubMed ID: 3259351
[TBL] [Abstract][Full Text] [Related]
18. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung.
Warren TK; Mitchell KA; Lawrence BP
Toxicol Sci; 2000 Jul; 56(1):114-23. PubMed ID: 10869459
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity.
Liu B; Mori I; Hossain MJ; Dong L; Takeda K; Kimura Y
J Gen Virol; 2004 Feb; 85(Pt 2):423-428. PubMed ID: 14769900
[TBL] [Abstract][Full Text] [Related]
20. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.
Jegerlehner A; Schmitz N; Storni T; Bachmann MF
J Immunol; 2004 May; 172(9):5598-605. PubMed ID: 15100303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
